616 related articles for article (PubMed ID: 22963896)
1. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
5. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
6. Review: SSRIs and TCAs equally effective at treating chronic depression and dysthemia; SSRIs are associated with fewer adverse events than TCAs.
Kocsis JH
Evid Based Ment Health; 2013 Aug; 16(3):82. PubMed ID: 23604275
[No Abstract] [Full Text] [Related]
7. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants versus placebo for depression in primary care.
Arroll B; Elley CR; Fishman T; Goodyear-Smith FA; Kenealy T; Blashki G; Kerse N; Macgillivray S
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007954. PubMed ID: 19588448
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
10. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
De Lima MS; Hotopf M
Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
Hirschfeld RM
J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
[TBL] [Abstract][Full Text] [Related]
14. Meta-analytical studies on new antidepressants.
Anderson IM
Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
[TBL] [Abstract][Full Text] [Related]
15. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
Steffens DC; Krishnan KR; Helms MJ
Depress Anxiety; 1997; 6(1):10-8. PubMed ID: 9394870
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis.
Undurraga J; Baldessarini RJ
J Psychopharmacol; 2017 Sep; 31(9):1184-1189. PubMed ID: 28633600
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.
Liu J; Dong J; Wang L; Su Y; Yan P; Sun S
PLoS One; 2013; 8(10):e76651. PubMed ID: 24098546
[TBL] [Abstract][Full Text] [Related]
19. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
Machado M; Iskedjian M; Ruiz I; Einarson TR
Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.
Skapinakis P; Bakola E; Salanti G; Lewis G; Kyritsis AP; Mavreas V
BMC Neurol; 2010 Jun; 10():49. PubMed ID: 20565960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
